nickname: EMA21b
url: https://www.ema.europa.eu/en/documents/referral/eli-lilly-company-limited-antibody-combination-bamlanivimab/etesevimab-covid19-article-53-procedure-assessment-report_en.pdf
title: "Eli Lilly and Company Limited use of bamlanivimab and etesevimab for the treatment of COVID-19"
journal: EMA
publisher: EMA
year: 2021
publish_date: "2021-03-16"
abstract: |-
  ([Full article](https://www.ema.europa.eu/en/documents/referral/eli-lilly-company-limited-antibody-combination-bamlanivimab/etesevimab-covid19-article-53-procedure-assessment-report_en.pdf))
